MELILLO, ROSA MARINA

MELILLO, ROSA MARINA  

Dipartimento di Medicina molecolare e Biotecnologie mediche  

Mostra records
Risultati 1 - 20 di 140 (tempo di esecuzione: 0.039 secondi).
Titolo Data di pubblicazione Autore(i) File
A new germline point mutation in Ret exon 8 (cys515ser) in a family with medullary thyroid carcinoma. 1-gen-2008 Fazioli, F.; Piccini, G.; Apolloni, G.; Bacciocchi, R.; Palmonella, G.; Recchioni, R.; Pierpaoli, E.; Silvetti, F.; Scarpelli, M.; Bruglia, M.; Melillo, ROSA MARINA; Santoro, Massimo; Boscaro, M. TACCALITI A.
Activation of RET oncogene and thyroid carcinogenesis 1-gen-1993 Santoro, Massimo; Grieco, M.; Melillo, ROSA MARINA; Carlomagno, F.; Cerrato, A.; Sabino, N.; Battaglia, C.; Fusco, Alfredo; Vecchio, Giancarlo
Activation of the Erk8 mitogen-activated protein (MAP) kinase by RET/PTC3, a constitutively active form of the RET proto-oncogene. 1-gen-2006 Iavarone, C; Acunzo, M; Carlomagno, Francesca; Catania, A; Melillo, ROSA MARINA; Carlomagno, MARIA STELLA; Santoro, Massimo; Chiariello, M.
Activation of TYRO3/AXL tyrosine kinase receptors in thyroid cancer. 1-gen-2011 Avilla, Elvira; Guarino, Valentina; Visciano, Carla; Liotti, Federica; Svelto, M.; Krishnamoorthy, GNAMA PRAKASAM; Franco, R.; Melillo, ROSA MARINA
Autocrine stimulation by osteopontin plays a pivotal role in the expression of the mitogenic and invasive phenotype of RET/PTC-transformed thyroid cells. 1-gen-2004 Castellone, MARIA DOMENICA; Celetti, Angela; Guarino, Valentina; Cirafici, A. M.; Basolo, F.; Giannini, R.; Medico, E.; Kruhoffer, M.; Orntoft, T. F.; Curcio, F.; Fusco, Alfredo; Melillo, ROSA MARINA; Santoro, Massimo
AXL Is a Novel Predictive Factor and Therapeutic Target for Radioactive Iodine Refractory Thyroid Cancer 1-gen-2019 Liotti, Federica; Prevete, Nella; Melillo, ROSA MARINA
AXL is an oncotarget in human colorectal cancer 1-gen-2015 Martinelli, Erika; Martini, Giulia; Cardone, Claudia; Troiani, Teresa; Liguori, Giuseppina; Vitagliano, Donata; Napolitano, Stefania; Morgillo, Floriana; Rinaldi, Barbara; Melillo, ROSA MARINA; Liotti, Federica; Nappi, Anna; Bianco, Roberto; Berrino, Liberato; Ciuffreda, Loreta Pia; Ciardiello, Davide; Iaffaioli, Vincenzo; Botti, Gerardo; Ferraiolo, Fiorella; Ciardiello, Fortunato
Basi molecolari dell’effetto pro-tumorigenico dele chemochine nel cancro della tiroide. 1-gen-2009 Melillo, ROSA MARINA
Biochemical and molecular characterization of the novel BRAF(V599Ins) mutation detected in a classic papillary thyroid carcinoma. 1-gen-2005 Moretti, S; Macchiarulo, A; DE FALCO, V; Avenia, N; Barbi, F; Carta, C; Cavaliere, A; Melillo, ROSA MARINA; Passeri, L; Santeusanio, F; Tartaglia, M; Santoro, Massimo; Puxeddu, E.
Biological role and potential therapeutic targeting of the chemokine receptor CXCR4 in undifferentiated thyroid cancer 1-gen-2007 DE FALCO, V; Guarino, V; Avilla, Elvira; Castellone, Md; Salerno, P; Salvatore, G; Faviana, P; Basolo, F; Santoro, Massimo; Melillo, ROSA MARINA
BRAF is a therapeutic target in aggressive thyroid carcinoma. 1-gen-2006 G., Salvatore; V., De Falco; P., Salerno; T. C., Nappi; Pepe, Stefano; Troncone, Giancarlo; Carlomagno, Francesca; Melillo, ROSA MARINA; S. M., Wilhelm; Santoro, Massimo
A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma. 1-gen-2007 Salvatore, G; Nappi, TITO CLAUDIO; Salerno, P; Jiang, Y; Garbi, Corrado; Ugolini, C; Miccoli, P; Basolo, F; Castellone, ; Cirafici, Am; Melillo, ROSA MARINA; Fusco, Alfredo; Bittner, Ml; Santoro, Massimo
Cloning and characterization of H4 (D10S170), a gene involved in RET rearrangements in vivo. 1-gen-1994 Grieco, M.; Cerrato, A.; Santoro, Massimo; Fusco, Alfredo; Melillo, ROSA MARINA; Vecchio, Giancarlo
CXC chemokine receptor 4 immunodetection in the follicular variant of papillary thyroid carcinoma: comparison to galectin-3 and hector battifora mesothelial cell-1. 1-gen-2010 Torregrossa, L.; Faviana, P.; Filice, M. E.; Materazzi, G.; Miccoli, P.; Vitti, P.; Fontanini, G.; Melillo, ROSA MARINA; Santoro, Massimo; Basolo, F.
CXCR4 expression correlates with the degree of tumor infiltration and BRAF status in papillary thyroid carcinomas. 1-gen-2012 Torregrossa, L; Giannini, R; Borrelli, N; Sensi, E; Melillo, ROSA MARINA; Leocata, P; Materazzi, G; Miccoli, P; Santoro, Massimo; Basolo, F.
Cytokines, Chemokines and thyroid remodeling 1-gen-2008 Melillo, ROSA MARINA
Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer. 1-gen-2002 Viglietto, G; Motti, Ml; Bruni, P; Melillo, ROSA MARINA; D'Alessio, A; Califano, D; Vinci, F; Chiappetta, G; Tsichlis, P; Bellacosa, A; Fusco, Alfredo; Santoro, M.
Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer. 1-gen-2002 Viglietto, G; Motti, Ml; Bruni, P; Melillo, ROSA MARINA; D'Alessio, A; Califano, D; Vinci, F; Chiappetta, G; Tsichlis, P; Bellacosa, A; Fusco, Alfredo; Santoro, Massimo
Different mutations of the RET gene cause different human tumoral diseases. 1-gen-1999 Santoro, Massimo; Melillo, ROSA MARINA; Carlomagno, Francesca; R., Visconti; DE VITA, Gabriella; G., Salvatore; Fusco, Alfredo; Vecchio, Giancarlo
Differential diagnosis of thyroid nodules using fine-needle aspiration cytology and oncogene mutation screening: are we ready? 1-gen-2010 Melillo, ROSA MARINA; Santoro, Massimo; Vecchio, Giancarlo